COS cells are a family of engineered monkey kidney cell lines widely used in molecular biology and biotechnology as workhorses for producing proteins from cloned genes. They originated from CV-1 cells, derived from the kidneys of African green monkeys, which were modified to permanently carry a piece of a virus called SV40. That viral insert gives COS cells a unique trick: when researchers introduce a DNA plasmid carrying the right viral sequence, the cells can copy that plasmid into tens of thousands of duplicates, churning out enormous amounts of whatever protein the plasmid encodes. This capability has made COS cells one of the most frequently used transient expression systems in biomedical research for over four decades.
Where COS Cells Come From
The name “COS” stands for “CV-1 Origin, SV40,” reflecting the two key ingredients. CV-1 is a cell line established from the kidney tissue of an African green monkey (species Chlorocebus aethiops). In the early 1980s, Yakov Gluzman at Cold Spring Harbor Laboratory introduced a mutant SV40 genome into CV-1 cells. The viral DNA was deliberately crippled so that it could not produce new virus particles, but it retained the gene encoding a protein called Large T antigen. That protein is the engine behind the system’s power.
Cells that successfully incorporated this defective SV40 DNA into their own chromosomes became the COS line. Because the SV40 genome integrated stably, every daughter cell inherits the ability to make Large T antigen without any further intervention from the researcher. The cells look and grow much like ordinary CV-1 cells in a dish, but they carry a hidden molecular amplifier waiting to be activated by the right plasmid.
The Amplification Trick
Large T antigen is a helicase, a molecular motor that unwinds DNA. In a normal SV40 infection, it latches onto a short stretch of viral DNA called the origin of replication (ori) and drives the virus to copy itself inside the host cell. COS cells exploit this machinery for a different purpose. When a researcher transfects a COS cell with a circular plasmid that contains the SV40 ori sequence, Large T antigen recognizes that ori and begins replicating the plasmid as if it were viral DNA. This replication is dramatic: a single cell can accumulate on the order of 50,000 to 100,000 copies of the plasmid, and any gene carried on that plasmid gets expressed at correspondingly high levels.1PubMed Central. Vectors bicistronically linking a gene of interest to the SV40 large T antigen in combination with the SV40 origin of replication enhance transient protein expression and luciferase reporter activity
This is what makes COS cells so attractive for transient expression, meaning short-term protein production without permanently modifying the cell. You clone your gene of interest into a plasmid that includes the SV40 ori, deliver it into COS cells, and within a few days you have large amounts of your protein to study. The whole process is fast. A researcher can go from a cloned gene to purified protein in roughly a week, far quicker than building a stable cell line.
Early work confirmed the kinetics of this replication. When COS-7 cells were fused with cells carrying a different plasmid that also contained an SV40 ori, replication kicked in with timing and magnitude resembling an actual SV40 infection.2PubMed Central. Amplification of a bovine papillomavirus-simian virus 40 chimera The system essentially mimics viral DNA amplification but without producing any infectious virus.
COS-1, COS-7, and Other Variants
Not all COS cells are identical. The two most commonly used variants are COS-1 and COS-7. Both descend from CV-1 cells transformed with defective SV40, but they arose from different transformation events, meaning the viral DNA integrated at different chromosomal locations and in different copy numbers. This leads to practical differences in the lab.
In head-to-head comparisons of transfection methods, COS-1 cells expressed higher amounts of recombinant protein than COS-7 cells under optimized conditions using DEAE-dextran-mediated DNA uptake followed by a brief DMSO shock.3Analytical Biochemistry. Maximal Expression of Recombinant cDNAs in COS Cells for Use in Expression Cloning That said, COS-7 cells remain extremely popular, partly because they are easier to obtain from cell banks and partly because they perform well enough for most applications.
A less commonly encountered variant is COS.M6, used particularly in membrane protein studies. Researchers investigating the vasopressin V2 receptor, for example, used COS.M6 cells to express mutant receptors and identify which amino acids are critical for moving the receptor to the cell surface.4Molecular Pharmacology. A Dileucine Sequence and an Upstream Glutamate Residue in the Intracellular Carboxyl Terminus of the Vasopressin V2 Receptor Are Essential for Cell Surface Transport in COS.M6 Cells The choice among variants often depends on the specific application, the protein being expressed, and the lab’s established protocols.
Getting DNA into COS Cells
The amplification trick only works if you can get the plasmid inside the cell in the first place. Over the years, researchers have tried numerous transfection methods with COS cells, and the results are not all equal. A systematic comparison found that DEAE-dextran-mediated uptake and protoplast fusion outperformed lipofection and electroporation for achieving high expression levels. Adding a short DMSO shock at the end of DEAE-dextran transfection boosted both the fraction of cells that took up DNA and the total amount of protein produced, without sacrificing the high per-cell expression rate.5Analytical Biochemistry. Maximal Expression of Recombinant cDNAs in COS Cells for Use in Expression Cloning
An older trick, coincubation with chloroquine during DEAE-dextran transfection, increased the number of transfected cells but actually reduced total protein output. The DMSO shock turned out to be the better optimization. These practical details matter quite a bit in the lab: a researcher producing protein for structural studies or bioassays needs maximal yield from every plate of cells, and small tweaks to the transfection protocol can make a two- or threefold difference.
What Researchers Use COS Cells For
The speed and high expression levels of COS cells have made them a go-to system for several categories of work. Their niche is situations where you need a moderate amount of correctly folded mammalian protein quickly, rather than industrial quantities over months.
Expression Cloning
One of the earliest and most impactful applications was expression cloning, a strategy for identifying unknown genes by forcing cells to make the protein and then screening for it. In a landmark demonstration, researchers built large plasmid cDNA libraries, transfected them into COS cells, and screened the cells with antibodies to find which plasmid encoded a protein of interest. This approach was used to clone the gene for CD28, a key receptor on immune T cells.6PubMed Central. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system The strategy depended on the massive amplification of plasmids inside COS cells: with so many copies of each plasmid per cell, the surface expression of the encoded protein was high enough to detect reliably with antibody binding.
Antibody Engineering
COS cells have played an important role in the development of genetically engineered monoclonal antibodies. When researchers modify an antibody gene and want to quickly produce enough of the resulting protein for biochemical and biophysical testing, COS cells provide a rapid production route. This is especially useful during the early screening phases when dozens of antibody variants need to be compared before committing to large-scale manufacturing.7Current Opinion in Biotechnology. Production of monoclonal antibodies in COS and CHO cells Once a lead candidate is selected, production typically shifts to Chinese hamster ovary (CHO) cells, which are better suited for stable, large-scale manufacturing.
Receptor and Membrane Protein Studies
Because COS cells are mammalian, they possess the cellular machinery to fold, modify, and traffic complex proteins to the correct locations. This makes them valuable for studying membrane receptors, ion channels, and transporters. Researchers routinely express mutant versions of receptors in COS cells to pinpoint which parts of the protein are essential for function or for reaching the cell surface, as seen in the vasopressin V2 receptor work described earlier.
Lentivirus Production
A more specialized application is using COS-1 cells to package recombinant lentiviruses, which are widely used tools for delivering genes into other cell types. Both COS-1 and HEK293T cells express SV40 Large T antigen and can amplify the packaging plasmids, but COS-1 cells offer practical advantages. One study found that the ratio of functional viral particles to total particles was three to four times higher in supernatants from COS-1 cells compared with HEK293T cells.8PubMed. Advantages of COS-1 monkey kidney epithelial cells as packaging host for small-volume production of high-quality recombinant lentiviruses COS-1 cells also adhered more firmly to plastic culture surfaces, reducing cell contamination in the viral supernatant and eliminating extra purification steps. This strong adhesion makes COS-1 cells attractive for automated, high-throughput lentivirus production in multi-well plates.9PubMed. COS-1 cells as packaging host for production of lentiviruses
Limitations and Quirks of the System
For all their convenience, COS cells are not without drawbacks. The transient nature of the expression system is both a strength and a weakness. Because the amplified plasmids are not integrated into the chromosome, they are gradually lost as cells divide. Protein production peaks within a few days of transfection and then declines. This makes COS cells poorly suited for applications requiring sustained production over weeks or months.
Cell death is another practical challenge. The massive plasmid replication and high-level protein production put the cells under significant stress, and many transfected cells die within days. Researchers have tried to extend the productive window. In one approach, overexpressing the anti-apoptotic protein Bcl-2 in COS-1 cells suppressed programmed cell death during late culture. Control cells stopped producing protein by day six, but Bcl-2-expressing cells continued longer, ultimately yielding about twice as much of the target protein.10Elsevier. Note Overexpression of bcl-2 improved survival of COS-1 cells and enhanced transient protein production
Another workaround involved growing COS-7 cells on positively charged microcarrier beads instead of flat plastic dishes. Cells on beads maintained attachment and protein secretion for longer periods, resulting in a roughly fivefold increase in total protein production from a single transfection over two weeks compared with standard monolayer culture.11PubMed Central. Sustained high-yield production of recombinant proteins in transiently transfected COS-7 cells grown on trimethylamine-coated (hillex) microcarrier beads
Post-Translational Modifications and Glycosylation Concerns
One reason researchers choose mammalian cells over bacteria or yeast for protein expression is that mammalian cells add sugar chains (glycosylation) and other chemical modifications to proteins in ways that closely resemble what happens in the human body. COS cells do carry out these modifications, but they do not always do so completely. Transient expression in COS cells has been noted to produce proteins that are incompletely glycosylated, though the proteins often retain their biological activity.12PubMed. Eukaryotic expression systems: a comparison
COS cells also have their own endogenous glycosylation enzymes that can modify expressed proteins in unexpected ways. Studies of fucosyltransferase activity in COS cells revealed that the cells express multiple fucosyltransferase gene homologs and carry endogenous glycosidase activities capable of trimming sugar residues off glycoproteins produced in the cells.13Oxford Academic. Expression of human a-L-fucosyltransferase gene homologs in monkey kidney COS cells and modification of potential fucosyltransferase acceptor substrates by an endogenous glycosidase For many applications this is a minor concern, but for experiments where precise glycan structures matter, researchers need to verify that the COS-produced protein matches the native form.
Endogenous Activities That Can Confound Experiments
A related issue, sometimes overlooked, is that COS cells are not a blank slate. They are monkey kidney cells with their own active genes, and some of those genes can interfere with results. A striking example emerged when researchers discovered that COS-7 and COS-1 cells endogenously express a functional dopamine transporter-like protein. This transporter showed high affinity for dopamine and its partial cDNA sequence was roughly 96% identical to the human dopamine transporter at the amino acid level.14FEBS Letters / PubMed Central. A cognate dopamine transporter-like activity endogenously expressed in a COS-7 kidney-derived cell line
This finding is a cautionary tale. If you are using COS cells to express a human dopamine transporter and study its pharmacology, the cell’s own transporter activity could contaminate your data. The endogenous transporter had low capacity, but it was clearly measurable and could skew results, particularly in sensitive binding or uptake assays. The same study noted that CHO cells and certain other lines did not show this activity, meaning the background is cell-line-specific. Researchers working with COS cells for neurotransmitter transporter studies need to run careful controls to distinguish their expressed protein from the cell’s own machinery.
COS Cells Versus CHO and HEK293T Cells
In the broader landscape of mammalian expression systems, COS cells occupy a specific niche. CHO (Chinese hamster ovary) cells dominate large-scale biopharmaceutical manufacturing, producing the majority of approved therapeutic antibodies and proteins. CHO cells excel at stable, long-term production, and regulatory agencies have decades of experience evaluating CHO-produced drugs. COS cells, by contrast, are better suited for the earlier, exploratory stages of research where speed matters more than scale.15Current Opinion in Biotechnology. Production of monoclonal antibodies in COS and CHO cells
HEK293T cells, derived from human embryonic kidney tissue and also expressing SV40 Large T antigen, are COS cells’ closest competitor for transient expression work. HEK293T cells offer the advantage of being human, which can matter when you want the most human-like protein modifications. But as noted in the lentivirus production context, HEK293T cells adhere poorly to plastic, causing cell contamination in supernatants. COS-1 cells avoided this problem entirely and produced higher-quality virus preparations, making them preferable for automated workflows.16PubMed. Advantages of COS-1 monkey kidney epithelial cells as packaging host for small-volume production of high-quality recombinant lentiviruses
The trade-off, in short: COS cells give you rapid, high-level protein production for screening and early characterization. When you need to move toward clinical-grade material or sustained manufacturing, you transition to CHO or another stable system.
COS Cells in Modern Microscopy
Beyond protein production, COS cells have become a favorite cell type for imaging and microscopy studies, partly because of their physical properties. COS-7 cells in particular are large, flat, and spread thinly on glass surfaces, which makes their internal structures easy to visualize. They are essentially nature’s demonstration slide for organelles.
Developers of advanced imaging techniques regularly use COS-7 cells as test subjects. In the development of grazing incidence structured illumination microscopy (GI-SIM), researchers repeatedly imaged COS-7 cells expressing fluorescent markers for the endoplasmic reticulum and microtubule network. They found that illuminating at an angle just below the critical angle for total internal reflection yielded a tenfold signal increase compared to standard TIRF illumination, enabling live-cell imaging of organelle dynamics at high resolution.17Cell. Grazing Incidence Structured Illumination Microscopy Enables High-Resolution Live-Cell Imaging
COS-7 cells also served as the model system for a label-free super-resolution technique called SR-FACT. Using this approach, researchers resolved six distinct organelle types in COS-7 cells without any fluorescent dyes or labels: the endoplasmic reticulum, mitochondria, late endosomes and lysosomes, lipid droplets, the nuclear membrane, and chromosomes.18Light: Science & Applications. Super-resolution fluorescence-assisted diffraction computational tomography reveals the three-dimensional landscape of the cellular organelle interactome The flat morphology of COS-7 cells was critical for these experiments: organelles near the glass surface remained within the illumination depth, producing clean images with minimal background. For this reason, COS-7 cells appear in the methods sections of microscopy papers with a frequency that far outstrips their use in other fields, and they have become something of a benchmark organism for validating new optical technologies.
Biosafety Considerations
Because COS cells carry SV40 Large T antigen, labs working with them need to follow biosafety guidelines appropriate for cells harboring viral oncogene sequences. The integrated SV40 genome is replication-deficient on its own, so COS cells do not produce infectious SV40 virus under normal circumstances. However, if a researcher introduces a plasmid that supplies the missing SV40 genes, recombination events could theoretically generate replication-competent virus. In practice, this risk is managed by using plasmids designed to minimize the overlap of sequences that could recombine with the integrated viral DNA.
Most institutional biosafety committees classify work with COS cells at Biosafety Level 1 or 2, depending on the nature of the recombinant DNA being introduced. When COS cells are used to package lentiviruses, the biosafety requirements reflect the lentiviral work rather than the COS cells themselves. Labs performing lentivirus production, whether in COS-1 or HEK293T cells, typically operate under BSL-2 with enhanced practices. The advantage of COS-1 cells in this context, their strong adhesion and low cell contamination in supernatants, can actually simplify containment by reducing the handling steps needed to clean up the viral preparation.19PubMed. COS-1 cells as packaging host for production of lentiviruses